International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1600
+0.0200 (14.29%)
Mar 26, 2026, 3:04 PM EST
International Stem Cell Market Cap
International Stem Cell has a market cap or net worth of $1.08 million as of March 26, 2026. Its market cap has increased by 23.85% in one year.
Market Cap
1.08M
Enterprise Value
8.21M
Revenue
9.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since January 9, 2007, International Stem Cell's market cap has decreased from 89.40M to 1.08M, a decrease of -98.79%. That is a compound annual growth rate of -20.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 1.08M | -3.57% |
| Dec 31, 2025 | 1.12M | 72.20% |
| Dec 31, 2024 | 650.76K | 31.13% |
| Dec 29, 2023 | 496.27K | -65.56% |
| Dec 30, 2022 | 1.44M | -61.95% |
| Dec 31, 2021 | 3.79M | 35.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carisma Therapeutics | 1.41M |
| Protagenic Therapeutics | 1.30M |
| CERo Therapeutics Holdings | 1.19M |
| Evofem Biosciences | 1.15M |
| Halberd | 1.10M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.03M |
| Avenue Therapeutics | 955.44K |